Annexin for cancer risk assessment

Details Annexin for cancer risk assessment Annexin for cancer risk assessment

G - Physics

01

N

G01N 33/574 (2006.01)

Patent

CA 2608306

The invention relates to the use of at least one annexin protein for the treatment of cancer, in particular of the urogenital and/or intestinal tract, and to a method for diagnosing cancer, particularly of the urogenital and/or intestinal tract, and/or for discrimination between cancerous and non- cancerous tissue.

L'invention concerne l'utilisation d'au moins une protéine d'annexine afin de traitement le cancer, en particulier, le cancer des voies urogénitales et/ou intestinales, ainsi qu'une méthode servant à diagnostiquer le cancer, en particulier, le cancer des voies urogénitales et/ou intestinales, et/ou à effectuer une distinction entre des tissus cancéreux et non cancéreux.

Affiliated with

Also associated with

Rating

Annexin for cancer risk assessment does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Annexin for cancer risk assessment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Annexin for cancer risk assessment will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1890278